Urgent.News

the world's headlines, one feed

Editions

Finance & Markets

Singaporean billionaire Lim Chap Huat sues Brookfield Asset Management for allegedly usurping $418M property deal

Billionaire Lim Chap Huat of Singaporean property firm Soilbuild Group is suing Brookfield Asset Management, accusing it of usurping a S$535.3 million (US$418.6 million) deal it had proposed as a joint venture.

Singaporean billionaire Lim Chap Huat sues Brookfield Asset Management for allegedly usurping $418M property deal

Singaporean billionaire Lim Chap Huat has filed a lawsuit against Brookfield Asset Management for allegedly usurping a $418 million property deal. The lawsuit, filed with Singapore's High Court, seeks unspecified damages over alleged breaches of contract and confidentiality surrounding Brookfield's May 2025 acquisition of three industrial properties in Singapore from Mapletree Industrial Trust for the specified amount.

The claimants in the lawsuit include Lim Chap Huat, his son Lim Han Qin, and a subsidiary of Soilbuild, while Brookfield, its Singapore unit, and a Brookfield-controlled entity are named as defendants. Brookfield had reportedly sought to partner with Soilbuild on the acquisition as a joint venture, but allegedly proceeded with the transaction without their consent just days before Mapletree announced the deal.

Brief written by urgent.news from VnExpress Business's own syndicated text. Machine-written — it may contain errors, so check the original before relying on it.

Read the original at e.vnexpress.net →

More in Finance & Markets

Celltrion Expands Market Presence in Spain and Portugal Through Tender Wins

Celltrion is rapidly strengthening its presence in Spain and Portugal, securing a series of government and regional tenders while expanding sales and marketing activities to drive prescriptions and…

  • Celltrion wins government tenders in Spain and Portugal, expanding market presence.
  • Omlyclo biosimilar dominates Spanish market with 90% share by June.
  • Actemra and other biosimilars gain significant market share in Spain and Portugal.